to expression of MHC class II following IFN-y stimulation. Hence, cell surface MHC class II expression on non-professional antigen presenting cells will be largely associated with CLIP after exposure to IFN-y. Only these cells, but not the cells that constitutively express MHC class II, will be the target for destruction by the autoreactive T cells that mediate CsA-AI (13) .
Development of CsA-AI in rats is basically dependent on two conditions. Firstly, the presence of the thymus is obligatory during the CsA treatment in order to generate autoreactive T cells (14, 15) . Secondly, total body irradiation is required for the elimination of the autoregulatory T cell compartment (4, 10) . Initially, a third prerequisite for development of CsA-AI was that the thymus had to be in the field of X-irradiation (1) . Although X-irradiation induces intrathymic changes in addition to the effects of CsA (16) , transplantation of newborn thymus lobes into thymectomized recipients after X-irradiation, but before CsA administration, consistently results in CsA-AI (15) . Therefore we concluded that X-irradiation of the thymus is not required for development of CsA-AI. Adoptive transfer studies have established that CsA-AI is T cell-mediated (14) . Moreover, the lesions of CsA-AI can be equally well elicited by CD4 or CD8 effector T cells and these subsets can generate identical macroscopic and microscopic signs of disease (17) . The requirements for the adoptive transfer of CsA-AI are slightly different from the induction of primary CsA-AI. The elimination of the autoregulatory system is still obligatory, but may also be achieved by sublethal X-irradiation as well as by cyclosphosphamide therapy (4). Obviously, additional intrathymic generation of autoreactive T cells by CsA is superfluous and indeed thymectomy of the secondary recipient does not alter the outcome of adoptively transferred CsA-AI (17) .
With respect to the role of cytokines there is only indirect evidence that CsA-AI is a disease mediated by type-l cytokines. We showed that clinically manifest CsA-AI is associated with a persistent increase in IFN -y producing CD45RC+RT6-T-helper cells (18) . Furthermore, examination of the cytokine production by pathogenic T cell clones revealed that these clones readily produced IL-2 and IFN-y, but not IL-4 or IL-IO (13) . The cytokine profile ofthe Tcells that have infiltrated the epidermal tissues remains to be determined. However, the up-regulation and induction of MHC class I and II molecules, respectively, as well as the associated macrophage infiltration in the affected tissues are also strongly indicative for the local production of type-l cytokines.
CENTRAL TOLERANCE: THE GENERA-TION OF AUTOREACTIVE T CELLS As already mentioned, the presence of the thymus during induction of CsA-AI, and in particular during the treatment with CsA, is essential for development of clinically manifest CsA-AI (14, 15) . Thymectomies performed at the end of the period of CsA administration or before adoptive transfer of autoreactive T cells to secondary recipients do not affect the incidence or severity of disease (15, 17) . These data indicate that CsA is only required for the intrathymic generation of autoreactive T cells responsible for induction of CsA-AI, and that these autoreactive T cells already leave the thymus during CsA treatment. After the discovery of the immunosuppressive actions of CsA in the late seventies, it took another decade before it was recognized that CsA had profound effects on the thymus. In vivo CsA treatment has been shown to have multiple effects on thymic stromal cells, as well as thymocyte maturation and selection (19) (20) (21) (22) . These effects are not directly explained by the way that CsA interferes with signal transduction. CsA blocks the calcineurindependent route of signal transduction typically used by T-cells upon T cell receptor (TCR) crosslinking (23, 24) . Therefore it is not antigen presentation by the stromal cells which is defective, but the response of the thymocytes following antigen presentation. Since the thymocyte response upon antigen recognition is dependent on the maturational stage of the responding cell, we hypothesized that CsA will have differential effects during distinct stages of T cell development (9) . Upon CsA administration the affinity of the TCR for the MHC-peptide complex remains the same, but the signal transduction upon cross-linking will be hampered. If the signal transduction is reduced, the cells will experience a diminished affinity! avidity interaction and will respond likewise. As a consequence only few cortical thymocytes will survive positive selection, whereas less self-reac-tive medullary thymocytes will be eliminated during negative selection. Indeed, in situ analysis revealed that CsA strongly increases the number of apoptotic cells in the thymic cortex, whereas the number of apoptotic cells in the cortico-medullary zone is decreased [Damoiseaux et al, Scand. J. Immunol., in press]. The outcome of these distinct effects of CsA on cortical and medullary thymocytes results in a maturation arrest of CD4+CD8+ double-positive thymocytes (22) , and a relative increase in the production of autoreactive T cells (19, 20) , respectively. In other words, since upon CsA administration thymocytes will experience a reduced affinity/avidity of the TCR for the MHC/peptide complex presented by the stromal cells, the affinity/avidity threshold for positive and negative selection will both shift to the right, i.e. increase. Altogether less thymocytes are selected but the thymocytes that are eventually selected exhibit on average a higher affinity.
PERIPHERAL TOLERANCE: CHARAC-TERIZATION OF AUTOREGULATORY T CELLS
The most interesting phenomenon in the model of CsA-AI is the existence of autoregulatory T cells in normal rats. These autoregulatory T cells are able to completely abrogate the autoreactive potential of pathogenic T cells. The presence of autoregulatory T cells was suspected because CsA alone is unable to induce CsA-AI; the elimination of the peripheral T cell compartment is essential for both induction and adoptive transfer of CsA-AI. Next, the adoptive transfer system enabled the characterization of the autoregulatory cells. When T cells isolated from a healthy normal rat are added to the effector T cells in a ratio of 2: 1 (normal cells:effector cells) no disease develops upon adoptive transfer. The phenotype ofthis host resistance mechanism in normal lymphocytes involves dual regulatory T cell subsets. A CD4 T cell subset must be co-transferred with a CD8 T cell subset in a ratio that approximates the normal CD4/CD8 T cell ratio in order to affect inhibition of the transfer of CsA-AI (10) . Furthermore, the autoregulatory capacity within the CD4 T cell compartment is confined to the CD45RC Iow Thelper cells since purified normal CD8 T cells together with normal CD45RChi gh-depleted T-helper cells completely abrogate the potential of autoreactive T cells to transfer CsA-AI (10). CD45RC defines two subpopulations of CD4 T cells with different cytokine profiles and functions (25) (26) (27) (28) . Several experimental systems have revealed a functional inter-regulation between the CD45RC high and CD45RC 1ow CD4 T cell subsets. In nude rats, the adoptive transfer of CD45RC high CD4 T cells from congenic euthymic donors induces a fatal wasting disease, while cotransfer of both subpopulations, or of the CD45RC!°W cells alone, has no effect (27) . It has been shown that lymphopenia-induced diabetes in PVG RT.l U rats or thyroidits in PVG RT.l c rats can also be prevented by adoptive transfer of CD45RCIow but not of CD45RChigh CD4 T cells (28, 29) . In the thyroiditis model, it has been found that IL-4 and TGF-B are involved in the immunoregulation mediated by the CD45RC 1ow CD4 T cell subpopulation (29) . Taken together, these data show that the CD45RChigh CD4 T cells contain T cells with a pathogenic potential, while the CD45RC 1ow CD4 T cells exhibit a regulatory function, and that the latter population has a dominant effect in regulating the former. However, unlike the CsA-AI model, the experimental autoimmune models mentioned above do not require CD8 T cells for autoregulatory function.
With respect to the origin of the autoregulatory T cells the focus has recently been set on the thymus (30) . In CsA-AI a delay of 14 days between X-irradiation and the transfer of effector cells results in complete resistance to the transfer of CsA-AI (4). Apparently, the autoregulatory system recovers within a period of about 1-2 weeks. Thymectomy prevents the reestablishment of the peripheral autoregulatory T cell circuit since thymectomy of secondary recipients elongates the possible delay period between X-irradiation and the transfer of effector cells for up to 6 weeks without affecting disease outcome (31) . More recently it has been confirmed that the autoregulatory T cells are formed in the thymus during CsA treatment but are not released to the periphery until cessation of CsA treatment (32) . Furthermore, subsequent studies revealed that tolerance to CsA-AI is mediated by a CD4+CD25+ subset of recent thymic emigrants (33) . Although the in vivo function of these autoregulatory T cells has been evaluated in the popliteal lymph node assay instead of the adoptive transfer model of CsA-AI, it may be anticipated that the CD4+CD2Y autoregulatory T cell subset is part of the CD45RClow T cell population. Indeed, in mice the cells that down-regulate inflammatory bowel disease are CD25+CD45RB'ow T-helper cells (34) . However, in lymphopenia-induced diabetes in PVG RT.l U rats the situation is less clear since autoregulatory T cells that could prevent diabetes were found in both CD25-and CD25+ subsets of CD45RCiow Thelper cells (35) . Although the T cells that downregulate CsA-AI are evidently induced in the thymus, they may be amplified in the periphery. The autoregulatory T cell compartment can be enhanced by T cell vaccination with 2000 rad Xirradiated syngeneic CsA-AI effector cells (36) . Besides a threefold enhancement of the autoregulatory T cell compartment, T cell vaccination also changed the requirement for both CD4 and CD8 T cell subsets. This study attributes the regulatory role to the CD4 T cell population, without further defining expression of CD45RC or CD25 (36).
PERIPHERAL TOLERANCE: GENETIC CONTROL
Whether CsA-AI eventually develops is not only dependent on the requirements as described above, but also on age and genetic factors. The rat model as originally described proved to be easily reproducible using young female LEW rats (RTP) (1, 31) ; males and females are equally susceptible. In two other studies, Louvain rats (Lou/M; RTI U) (37) and PVG rats (RTIC) (52) were shown to be susceptible as well. On the other hand, Brown Norway rats (BN; RTI n) (38) and Dark Agouti rats (DA; RTI a) (52) appear to be resistant. Also in mice CsA-AI appears to be age dependent and strain specific (39, 40) . Since susceptibility to CsA-AI in mice does not correlate with inhibition of clonal deletion in the thymus (41) , there may be a difference in peripheral tolerance induction. Indeed, similar to the age-related resistance in LEW rats (31), the strain-related resistance in mice is the result of increased amounts of autoregulatory T cells in the bone marrow inoculum (42) . Whether these autoregulatory T cells are identical to the "natural suppressor" T cells as identified in murine bone marrow and belonging to the NK1.1+ T cell family (43), remains to be determined. However, this seems not to be the case for the strain-related resistance as observed in BN rats since BN rats remain resistant to induction ofCsA-AI upon depletion of the Tcells in the bone marrow inoculum [Damoiseaux et at, unpublished results]. The influence of genetic factors has been mainly explored in susceptible LEW rats and resistant BN rats. The use of MHCcongenic rats, LEW-IN (RTI n) andBN-IL (RTI '), has revealed that susceptibility is independent of the MHC haplotype and is predominantly determined by non-MHC gene effects (44) . The resistance of BN rats is not the result of the lack of target organ susceptibility due to the absence of the target autoantigen as has been demonstrated in. three independent experimental settings. Firstly, both BN as well as BN-IL rats consistently develop the characteristic macroscopic and microscopic signs of CsA-AI upon adoptive transfer with effector T cells derived from diseased LEW-IN and LEW rats, respectively (44) . Secondly, although opposing results have been obtained with respect to susceptibility of (LEW x BN)F 1 rats (44, 45) , (LEW x BN)F 1 into parent bone marrow chimeras results in clinically manifest disease in both LEW and BN recipients (46) . And thirdly, resistant BN-IL rats could be rendered susceptible to CsA-AI by reconstituting thymectomized and lethal X-irradiated BN-IL rats with LEW bone marrow cells and LEW neonatal thymus lobes (47) . These experiments also demonstrate that susceptibility versus resistance in LEW and BN rats is the result of intrinsic factors in the bone marrow stem cells.
In search of a possible difference in autoregulatory T cells between rat strains that are susceptible (LEW and PVG) or resistant (BN and DA) to CsA-AI, we recently have determined the CD45RC high/RCiow ratio within the CD4 T cell compartment of naive rats (52) . The results obtained reveal that the resistant rat strains have a preponderance of the autoregulatory CD45RC'ow T-helper cells, whereas in the susceptible rat strains the potentially pathogenic CD45RChigh T-helper cells predominate. Whether this difference in CD45RChigh/RC low ratio within the CD4 T cell compartment is functional with respect to determining susceptibility or resistance to CsA-AI awaits further elucidation. Recent studies on the balance between CD45RChigh and CD45RC'ow CD4 T cells in LEW and BN rats have shown that this balance is also intrinsic to bone marrow-derived cells and is genetically controlled (26) . Using bone marrow chimeras, we showed that the difference in the CD45RChigh/RClow CD4 T cell ratio between naive LEW and BN rats is intrinsic to hemopoietic cells. Furthermore, a genome-wide search for loci controlling the balance between T cell subpopulations was conducted in a (LEW x BN)F 2 intercross. Genome scanning identified one quantitative trait locus on chromosome 9. In addition, two regions on chromosomes 10 and 20 that contain, respectively, a cytokine gene cluster and the MHC region were suggestive for linkage. Interestingly, overlapping regions on these chromosomes have been implicated in the susceptibility to various immune-mediated disorders (48) (49) (50) . The identification and functional characterization of genes in these regions controlling the CD45RChigh/RClow Th cell subpopulations may shed light on key regulatory mechanisms of pathogenic immune responses.
CONCLUSIONS
The CsA-AI autoimmune model is, in contrast to many experimental autoimmune models that are induced by immunization with a foreign protein in adjuvant, an interesting physiological autoimmune model based on defective T cell development including aberrant selection in the thymus and disturbed T cell balances in the periphery. Apparently, both central as well as peripheral tolerance has to be disturbed for development of clinically manifest CsA-AI. In this case peripheral tolerance concerns dominant T cell tolerance, as it still operates in the presence of potentially pathogenic autoreactive T cells; this distinguishes it from other forms of peripheral tolerance that are caused by recessive mechanisms, such as T cell deletion or anergy induction (51) . Since autoregulatory T cells originate in the thymus it is a philosophical question whether dominant T cell tolerance is a matter of central or peripheral tolerance. Anyway, dominant T cell tolerance is centrally induced, but operates in the periphery. More interesting is to explore developmental pathways of autoregulatory T cells in the thymus and whether CsA interferes with these pathways. Evidently CsA prevents the emigration from the thymus into the periphery, but whether CsA also interferes with possible intrathymic selection events remains to be determined.
